Lamprou Vasileios, Varvarousis Dimitrios, Polytarchou Kali, Varvarousi Giolanda, Xanthos Theodoros
National and Kapodistrian University of Athens, Medical School, MSc "Cardiopulmonary Resuscitation,", Athens, Greece.
Department of Cardiology, General Hospital of Nikea, Piraeus, Greece.
Clin Cardiol. 2017 Aug;40(8):528-533. doi: 10.1002/clc.22689. Epub 2017 Mar 10.
The prognosis of acute coronary syndromes (ACS) is affected by many factors. Normal thyroid homeostasis is known to alter during various critical illnesses, a condition that has been shown to correlate with the severity of the disease and increased mortality. The purpose of this article is to review literature to emphasize the considerable association of thyroid function with the cardiovascular system and summarize all existing evidence with regard to the role of thyroid hormones alterations during ACS. The electronic databases of PubMed, Medline, Scopus, and Cochrane were searched for relevant literature and studies. Alterations in thyroid hormone plasma concentrations, especially low triiodothyronine (T3) levels, represent a hormonal imbalance that is not uncommon among patients suffering an acute coronary event. Many studies have identified this abnormal thyroid hormonal status to be related to worse prognosis. Although further large-scale clinical trials are needed, the low T3 syndrome manifesting in patients during ACS might be useful in prognostic stratification.
急性冠状动脉综合征(ACS)的预后受多种因素影响。已知在各种危重病期间甲状腺内环境稳定会发生改变,这种情况已被证明与疾病严重程度及死亡率增加相关。本文旨在回顾文献,强调甲状腺功能与心血管系统之间的密切关联,并总结关于急性冠状动脉综合征期间甲状腺激素改变作用的所有现有证据。检索了PubMed、Medline、Scopus和Cochrane等电子数据库中的相关文献和研究。甲状腺激素血浆浓度的改变,尤其是低三碘甲状腺原氨酸(T3)水平,代表了一种激素失衡,在急性冠状动脉事件患者中并不罕见。许多研究已确定这种异常甲状腺激素状态与更差的预后相关。尽管需要进一步的大规模临床试验,但急性冠状动脉综合征患者出现的低T3综合征可能有助于预后分层。